**
Emerging research from Mount Sinai has unveiled startling findings regarding the presence of per- and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals,” in umbilical cord blood. This pivotal study indicates that fetuses are likely exposed to a far greater array of these harmful substances than previously understood, raising urgent questions about the potential health challenges facing newborns.
Expanding the Scope of PFAS Research
Traditionally, testing of umbilical cord blood has focused on a limited selection of PFAS compounds, primarily perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, the recent Mount Sinai study involved an extensive analysis of 120 umbilical cord blood samples, previously assessed for just four compounds. By employing a more comprehensive “non-targeted analysis,” researchers identified an astonishing 42 different PFAS compounds across these samples, revealing significantly higher total PFAS levels than earlier studies had suggested.
Shelley Liu, an associate professor at the Icahn School of Medicine at Mount Sinai and co-author of the study, emphasised the importance of these findings. “Babies are exposed to many more PFAS than we previously thought,” she stated. This exposure occurs during a particularly vulnerable period of development, underscoring the need for greater awareness and understanding of the implications.
The Health Risks of PFAS Exposure
PFAS are a broad class of approximately 15,000 synthetic chemicals known for their water-, stain-, and grease-resistant properties. However, their persistence in the environment and human body has raised alarm bells. Research links these chemicals to serious health issues, including cancer, birth defects, immune system dysfunction, elevated cholesterol levels, and kidney disease. The term “forever chemicals” aptly describes their resistance to natural degradation, resulting in long-lasting contamination.
A comprehensive review of 40 studies found PFAS present in every one of the 30,000 umbilical cord blood samples analysed. Higher maternal PFAS levels correlate with increased risks of infant mortality, low birth weight, and obesity in later life. Furthermore, fetal exposure has been associated with a heightened likelihood of developing cancer, neurological disorders, and cardiovascular diseases as children grow.
The most notorious PFAS compounds, such as PFOA and PFOS, were prevalent until their phasedown in recent years, replaced by newer generations of PFAS that manufacturers claim are less harmful. However, evidence supporting these claims remains scarce, and concerns persist that these newer compounds may degrade into other harmful substances within the environment or human body.
Regulatory Challenges and Testing Shortcomings
As awareness of PFAS-related health risks grows, regulatory bodies have struggled to keep pace with the evolving landscape of these chemicals. The U.S. Environmental Protection Agency (EPA), for instance, employs testing methodologies that typically cover only 30 to 40 PFAS compounds in water samples, despite independent researchers discovering thousands of different PFAS in various environmental contexts. A 2022 analysis highlighted significant undercounting of PFAS levels in water by regulators, showcasing a critical gap in monitoring efforts.
The Mount Sinai study juxtaposed traditional PFAS testing methods with the broader, non-targeted approach. As anticipated, the latter revealed an expanded array of PFAS compounds. While the EPA has recently approved a blood test for 53 PFAS compounds, Liu noted that their research detected 31 additional compounds not included in the EPA’s testing parameters.
Implications for Infant Health
While the Mount Sinai study did not delve into the direct health consequences of elevated PFAS levels in fetal blood, the correlation between higher PFAS concentrations and increased health risks is compelling. The samples analysed were drawn as part of the federal government’s ongoing Home Study, which tracks individuals’ PFAS exposure and health outcomes over time. Liu and her team plan to investigate the potential health implications of their findings further.
The research underscores a critical point: the extent of harm inflicted on infants exposed to a myriad of PFAS chemicals has likely been underestimated due to the limitations in current measurement methodologies. David Andrews, acting chief science officer at the Environmental Working Group, a non-profit not involved in the study, stated, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
The implications of this research are profound. As we grapple with the reality of PFAS contamination, it is evident that the health of future generations hangs in the balance. The findings compel us to rethink our regulatory frameworks and take decisive action to protect vulnerable populations, particularly the unborn. Understanding the full spectrum of PFAS exposure is not merely an academic exercise; it is a crucial step towards safeguarding public health and ensuring that no child is born into a world tainted by toxic chemicals.
